Sort
35,931 grants matching “parkinsons”
FAMILY STUDY OF STROKE RISK AND CAROTID ATHEROSCLEROSIS
$736,156Ralph Lewis Sacco · University Of Miami School Of Medicine · R01 · FY2009 · NS
Investigating neuroanatomical underpinnings of apathy in ADRD through neuroimaging and electrical manipulation
$736,141Nora Vanegas-Arroyave · Baylor College Of Medicine · R01 · FY2025 · MH
Next-generation high-resolution diffusion MRI resolving cortical columns and layers in vivo
$736,036Allen W Song · Duke University · R01 · FY2019 · EB
PESTICIDES AND RISK IN THE AGRICUTURAL HEALTH STUDY
$735,925Parkinson'S Institute · R01 · FY2003 · ES
PESTICIDES AND RISK IN THE AGRICUTURAL HEALTH STUDY
$735,925Parkinson'S Institute · R01 · FY2002 · ES
Research Resource for Complex Physiologic Signals
$735,628Ary L Goldberger · Beth Israel Deaconess Medical Center · U01 · FY2010 · EB
In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells
$735,392Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2008 · HD
Advancing Pantothenate Kinase Activation Therapy
$735,373Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
Biomarkers of Oxidative Stress in Parkinson's Disease
$735,348M Flint Beal · Weill Medical Coll Of Cornell Univ · RC2 · FY2009 · AT
Alpha Synuclein, cellular dysfunction and Parkinson disease
$735,321Mark Cookson · National Institute On Aging · ZIA · FY2023 · AG
Center for Caenorhabditis Elegans Anatomy
$735,131David H. Hall · Albert Einstein College Of Medicine · R24 · FY2010 · RR
Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors
$734,961Georgios Skiniotis · Stanford University · R01 · FY2018 · NS
Development of Drugs Acting at Adenosine Receptors
$734,314Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
RESTORATION OF DOPAMINE FUNCTION IN PARKINSON'S DISEASE
$734,088University Of Kentucky · P50 · FY2004 · NS
Dietary Modification Of Brain Aging And Neurodegenerative Disorders
$734,001Mark Mattson · National Institute On Aging · ZIA · FY2013 · AG
Development of marmoset models of neurodegenerative disease using embryonic stem cell-based gene-editing approaches
$733,301Kuo-Fen Lee · Salk Institute For Biological Studies · R24 · FY2020 · OD
Thalamo-Cortical Plasticity: Sensory Denervation and Loss of Dopamine
$733,235Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Early development of small molecule neuroprotectants.
$733,123Corinne Ida Lasmezas · Scripps Florida · R01 · FY2021 · NS
Male pesticide exposure, reproductive health and epigenetics
$733,114Lidia Minguez Alarcon · Brigham And Women'S Hospital · R01 · FY2023 · ES
AGING AND DOPAMINE GRAFTS IN PARKINSONIAN MONKEYS
$733,082Rush University Medical Center · R01 · FY2000 · AG
CORE--RELIGIOUS ORDERS STUDY
$732,922David A Bennett · Rush University Medical Center · P30 · FY2008 · AG
Neurodegeneration and Brain Function in Aging with HIV and Parkinson's Disease
$732,881Tilman Schulte · Sri International · R01 · FY2015 · AA
ALZHEIMER'S DISEASE RESEARCH CENTER
$732,844Daniel C Marson · University Of Alabama At Birmingham · P50 · FY2009 · AG
Thalamo-Cortical Plasticity: Sensory Denervation and Loss of Dopamine
$732,301Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Transcranial focused ultrasound for head and neck cancer pain. A pilot study
$731,880William Jeffrey Elias · University Of Virginia · UH3 · FY2019 · NS